Baby Safety / Compounds / Erythritol

Is Erythritol safe for babies and kids?

Moderate risk for kids

Infants are more vulnerable to Erythritol than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

What is erythritol?

The IUPAC name is (2S,3R)-butane-1,2,3,4-tetrol.

Also known as: (2S,3R)-butane-1,2,3,4-tetrol, meso-Erythritol, Phycitol, Erythrit.

IUPAC name
(2S,3R)-butane-1,2,3,4-tetrol
CAS number
149-32-6
Molecular formula
C4H10O4
Molecular weight
122.12 g/mol
SMILES
C(C(C(CO)O)O)O
PubChem CID
222285

Risk for babies

Moderate risk

Infants are more vulnerable to Erythritol than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.

What to do: Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Risk for pregnant and nursing people

Context-dependent

Pregnancy alters the metabolism and distribution of Erythritol, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Regulatory consensus

3 regulatory and scientific bodies have classified Erythritol. The classifications differ — that's the data.

AgencyYearClassificationNotes
US FDA / EFSA (Erythritol — E968 — FDA GRAS (21 CFR 184.1277 — affirmed GRAS as direct food additive; also multiple GRAS notices — GRN 000076 Nikken Chemicals; approximately zero-calorie sugar alcohol — 0.24 kcal/g vs 4 kcal/g sucrose); EFSA E968 opinion — ADI 'not specified' (2010 re-evaluation); WHO/JECFA: ADI 'not specified'; naturally occurring in small amounts in mushrooms, grapes, melons, fermented foods, human blood; commercially produced by fermentation of glucose using Moniliella pollinis or Candida magnoliae; approximately 70% sweetness of sucrose; minimal osmotic laxative effect at typical consumption levels (absorbed from small intestine — ~90% absorbed, excreted renally — distinguishes it from poorly absorbed sugar alcohols like sorbitol/mannitol); does not cause dental caries; 2023 Nature Medicine paper (Hazen et al.) reported epidemiological association between circulating erythritol levels and cardiovascular events (MACE) — correlation between endogenous erythritol and/or dietary erythritol intake and cardiovascular risk — findings require independent replication and regulatory bodies have not changed GRAS status; no carcinogenicity classification by IARC, NTP, US EPA, or EFSA)2023no carcinogenicity classification; FDA GRAS 21 CFR 184.1277; EFSA E968 ADI not specified; WHO/JECFA ADI not specified; ~0.24 kcal/g; ~90% absorbed renally excreted (minimal laxative effect); 2023 epidemiological CV association signal (Hazen et al.) — under review, GRAS status unchanged; not classified by IARC, NTP, or EPA for carcinogenicity
EPA CTX / GenetoxGenotoxicity: negative (Ames: negative, 0 positive / 2 negative reports)
EPA CTX / GenetoxGenotoxicity: negative (Ames: negative, 0 positive / 2 negative reports)

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter erythritol

  • Industrial FacilitiesManufacturing plants, Chemical storage areas, Waste treatment sites
  • Occupational EnvironmentsFactories, Warehouses, Transportation vehicles
  • Consumer Productsdietary supplements, fortified foods, energy drinks

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Erythritol:

  • Ester quats (diethyl ester dimethyl ammonium chloride)
    Trade-offs: Slightly different performance feel
    Relative cost: 1.2-2×

Frequently asked questions

Is erythritol safe for kids?

Infants are more vulnerable to Erythritol than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

What products contain erythritol?

Erythritol appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments); dietary supplements (Consumer products).

What should I do if my child is exposed to erythritol?

Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Why do regulators disagree about erythritol?

Erythritol has been classified by 3 agencies including US FDA / EFSA (Erythritol — E968 — FDA GRAS (21 CFR 184.1277 — affirmed GRAS as direct food additive; also multiple GRAS notices — GRN 000076 Nikken Chemicals; approximately zero-calorie sugar alcohol — 0.24 kcal/g vs 4 kcal/g sucrose); EFSA E968 opinion — ADI 'not specified' (2010 re-evaluation); WHO/JECFA: ADI 'not specified'; naturally occurring in small amounts in mushrooms, grapes, melons, fermented foods, human blood; commercially produced by fermentation of glucose using Moniliella pollinis or Candida magnoliae; approximately 70% sweetness of sucrose; minimal osmotic laxative effect at typical consumption levels (absorbed from small intestine — ~90% absorbed, excreted renally — distinguishes it from poorly absorbed sugar alcohols like sorbitol/mannitol); does not cause dental caries; 2023 Nature Medicine paper (Hazen et al.) reported epidemiological association between circulating erythritol levels and cardiovascular events (MACE) — correlation between endogenous erythritol and/or dietary erythritol intake and cardiovascular risk — findings require independent replication and regulatory bodies have not changed GRAS status; no carcinogenicity classification by IARC, NTP, US EPA, or EFSA), EPA CTX / Genetox, EPA CTX / Genetox, with differing conclusions. Regulators apply different standards of evidence (animal data weighting, exposure-pattern assumptions, epidemiological power thresholds), which is why two scientific bodies can review the same data and reach different conclusions. See the regulatory consensus table on this page for the full picture.

See Erythritol in the baby app

Look up products containing erythritol, compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (1)

  1. FDA GRAS 21 CFR 184.1277 Erythritol GRN 000076; EFSA E968 ADI Not Specified 2010; WHO JECFA ADI Not Specified; ~90% Small Intestinal Absorption Renal Excretion; Minimal Laxative Effect; Non-Cariogenic; 2023 Hazen et al Nature Medicine Cardiovascular Association MACE Platelet Aggregation; GRAS Status Unchanged; No IARC NTP EPA EFSA Carcinogenicity Classification (2023) — regulatory

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →